RE:My concernYou seem to miss the ENTIRE POINT of a lockdown. It is to have people STAY HOME.
It doesnt matter that the office is safe and can detect covid or not when we don't want anyone travelling TO the office. You can catch it on your way or when you leave in any of your travels either way, not just at your work destination. These smaller sizes of office spaces where client traffic is minimal are closed for a reason and wlll be perfect for the commercial units when the time comes.
As for now, because of the lockdown, industry and factories should be more the focus for the industrial version Biocloud as they ARE open and employees in large numbers ARE coming to them.
This is the crucial part to Biocloud demand and its breakout story as I see it: WHEN WE START TO RETURN, we will want spaces to be safe and PROVEN so.
Once an office like ours re-opens (like many others) I would be shocked if Kontrol didnt have Bioclouds up and running in its own space. Of course that would be of concern.
If anything, this is the reason for the lag with Biocloud so far. Everything is all about vaccines and lockdowns and distancing/masks.
When the focus returns to "now that the pandemic is under some control, what do we do to re-open safely and prevent further breakout and spreads in the smaller and average settings."
THEN it wil be our moment to shine. And with all they have and are putting into that scenerio, we look like we will be ready and ready to accomodate the demand.
Thats how I see it playing out and it should start happening in late spring if these lockdowns and vaccines start having some positive effects. Until then, we wait. We wait to see the volume we are all desperate to see.
And if you are invested, have to believe we WILL see.
GLTAL